BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17196385)

  • 1. Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists.
    Hall A; Atkinson S; Brown SH; Chessell IP; Chowdhury A; Giblin GM; Goldsmith P; Healy MP; Jandu KS; Johnson MR; Michel AD; Naylor A; Sweeting JA
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1200-5. PubMed ID: 17196385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.
    Hall A; Atkinson S; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Gleave RJ; Hammond B; Healy MP; Johnson MR; Michel AD; Naylor A; Novelli R; Spalding DJ; Tang SP
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3657-62. PubMed ID: 16697196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.
    Hall A; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Hammond B; Healy MP; Johnson MR; Metcalf A; Michel AD; Naylor A; Novelli R; Spalding DJ; Sweeting J
    Bioorg Med Chem Lett; 2007 Feb; 17(3):732-5. PubMed ID: 17098427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives.
    Hall A; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Hammond B; Healy MP; Johnson MR; Metcalf A; Michel AD; Naylor A; Novelli R; Spalding DJ; Sweeting J; Winyard L
    Bioorg Med Chem Lett; 2007 Feb; 17(4):916-20. PubMed ID: 17175160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists.
    Hall A; Brown SH; Chowdhury A; Giblin GM; Gibson M; Healy MP; Livermore DG; Wilson RJ; Naylor A; Rawlings DA; Roman S; Ward E; Willay C
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4450-5. PubMed ID: 17574410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
    Hall A; Billinton A; Brown SH; Clayton NM; Chowdhury A; Giblin GM; Goldsmith P; Hayhow TG; Hurst DN; Kilford IR; Naylor A; Passingham B; Winyard L
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3392-9. PubMed ID: 18462938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.
    Hall A; Billinton A; Bristow AK; Brown SH; Chowdhury A; Cutler L; Giblin GM; Goldsmith P; Hayhow TG; Kilford IR; Naylor A; Passingham B; Rawlings DA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4027-32. PubMed ID: 18571922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel methylene-linked heterocyclic EP1 receptor antagonists.
    Hall A; Bit RA; Brown SH; Chowdhury A; Giblin GM; Hurst DN; Kilford IR; Lewell X; Naylor A; Scoccitti T
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1592-7. PubMed ID: 18262416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel biaryl heterocyclic EP1 receptor antagonists.
    Hall A; Bit RA; Brown SH; Chaignot HM; Chessell IP; Coleman T; Giblin GM; Hurst DN; Kilford IR; Lewell XQ; Michel AD; Mohamed S; Naylor A; Novelli R; Skinner L; Spalding DJ; Tang SP; Wilson RJ
    Bioorg Med Chem Lett; 2006 May; 16(10):2666-71. PubMed ID: 16503138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Diarylthiophenes as selective EP1 receptor antagonists.
    Ducharme Y; Blouin M; Carrière MC; Chateauneuf A; Côté B; Denis D; Frenette R; Greig G; Kargman S; Lamontagne S; Martins E; Nantel F; O'Neill G; Sawyer N; Metters KM; Friesen RW
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1155-60. PubMed ID: 15686932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
    Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new chemical leads for selective EP1 receptor antagonists.
    Naganawa A; Saito T; Nagao Y; Egashira H; Iwahashi M; Kambe T; Koketsu M; Yamamoto H; Kobayashi M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2006 Aug; 14(16):5562-77. PubMed ID: 16697646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.
    Asada M; Obitsu T; Nagase T; Sugimoto I; Yamaura Y; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem; 2009 Sep; 17(18):6567-82. PubMed ID: 19700331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.
    Asada M; Obitsu T; Kinoshita A; Nakai Y; Nagase T; Sugimoto I; Tanaka M; Takizawa H; Yoshikawa K; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2639-43. PubMed ID: 20346663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists.
    Naganawa A; Matsui T; Ima M; Yoshida K; Tsuruta H; Yamamoto S; Yamamoto H; Okada H; Maruyama T; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2006 Dec; 14(23):7774-89. PubMed ID: 16931028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further optimization of sulfonamide analogs as EP1 receptor antagonists: synthesis and evaluation of bioisosteres for the carboxylic acid group.
    Naganawa A; Matsui T; Ima M; Saito T; Murota M; Aratani Y; Kijima H; Yamamoto H; Maruyama T; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem; 2006 Nov; 14(21):7121-37. PubMed ID: 16879970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel glycine sulfonamide antagonists for the EP1 receptor.
    McKeown SC; Hall A; Blunt R; Brown SH; Chessell IP; Chowdhury A; Giblin GM; Healy MP; Johnson MR; Lorthioir O; Michel AD; Naylor A; Lewell X; Roman S; Watson SP; Winchester WJ; Wilson RJ
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1750-4. PubMed ID: 17236765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EP1 antagonists for the treatment of inflammatory pain.
    Hall A; Billinton A; Giblin GM
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):597-612. PubMed ID: 17786859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR).
    Mehlmann JF; Crawley ML; Lundquist JT; Unwalla RJ; Harnish DC; Evans MJ; Kim CY; Wrobel JE; Mahaney PE
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5289-92. PubMed ID: 19683924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.